This may be related to increased levels of TNF-alpha, IL-1beta, and IL-6, all of which have been shown to stimulate DAF expression [25], [26] and to be involved in the pathogenesis of NASH [27]. The gene discussed is CD55; the disease is metabolic dysfunction-associated steatohepatitis.